CCSD code H5230 – Haemorrhoid sclerosing injection

Key takeaways

CCSD code H5230 covers injection of a sclerosing substance into internal haemorrhoids. External haemorrhoids and banding take other codes.

The descriptor is plural, so one H5230 normally covers every site injected in a session. Confirm the billing unit with each insurer.

Many insurers require pre-auth for surgical-schedule procedures, so check each insurer’s current rules before the appointment.

The operative note must name the sclerosing agent, the haemorrhoid grade, the number of sites injected and the proctoscope used.

Pabau, the practice management platform we build, stores each insurer’s agreed rate and authorisation code, then sends the claim through Healthcode.

CCSD Code H5230: definition and clinical scope

CCSD Code H5230 is the Clinical Coding and Schedule Development procedure code for the injection of a sclerosing substance into haemorrhoids. The CCSD Group places it in section 11.6.0 (Rectum/Anus) of its schedule, which UK private specialists use to bill consultant procedures.

CCSD codes are not NHS procedure codes. In fact, UK private medical insurers (PMIs) widely use them, and each insurer applies its own rules and fee schedule. The neighbouring Rectum/Anus codes each have their own entry in our CCSD code guides.

Next, the quick-reference table below summarises the core facts a coder needs before submitting an H5230 claim.

The procedure: injection of sclerosing substance into haemorrhoids

Haemorrhoid sclerotherapy is a minimally invasive outpatient treatment for Grade I, Grade II and selected Grade III haemorrhoids on the Goligher scale. The colorectal surgeon introduces a proctoscope to see the internal haemorrhoids above the dentate line. They then inject a sclerosing agent into the submucosa of the vascular pedicle at each affected site.

The sclerosant most commonly used in UK practice is 5% phenol in almond oil. However, clinicians may use other formulations at their discretion, and the operative note must name whichever agent they gave. The injection triggers fibrosis in the submucosal vascular pedicle, so the haemorrhoidal tissue shrinks and fixes to the underlying rectal wall.

A typical session involves the following steps:

1. Patient positioned in the left lateral or lithotomy position
2. Proctoscope introduced and the internal haemorrhoids visualised above the dentate line
3. Sclerosing agent drawn up and confirmed (agent and volume recorded in the procedure note)
4. Injection made into the submucosa at each haemorrhoid site (commonly up to three sites per session)
5. Proctoscope removed; no sutures or dressings required
6. Post-procedure care instructions provided; patient discharged same-day

External haemorrhoids and perianal skin tags are not suitable for sclerotherapy and are outside the clinical scope of H5230. Instead, a different code or procedure applies when external pathology is the main presentation.

What H5230 covers and what it excludes

Haemorrhoid codes sit close together in the H-series, so the wrong one is easy to pick. The table below sets out what H5230 includes and which procedures fall outside it. In fact, CCSD lists every coded procedure in the right-hand column as an unacceptable combination with H5230.

CCSD’s combination rules are principles, and each insurer decides whether to adopt them. So check the insurer’s own schedule if a claim queries a combination.

How H5230 sits in the CCSD H-series: neighbouring codes

The CCSD H-series covers colorectal procedures, and H5230 sits within a cluster of haemorrhoid codes that billers often confuse. Bupa’s procedure fee schedule and the Healix fee schedule both publish H-series rates. Also, they serve as a practical reference for checking fee levels alongside the correct code.

When can a proctoscopy code be billed alongside H5230? Proctoscopy (H6260) is integral to H5230, so you do not code it separately alongside H5230. The proctoscope delivers the injection, so it is part of the procedure rather than a separate diagnostic act. However, where the surgeon excises the haemorrhoids rather than injecting them, the claim moves to H5100 instead.

Documentation requirements for a valid H5230 claim

Insurers can decline an H5230 claim when the operative note does not support the code. The CCSD technical guide requires that the procedure documentation supports the specific code claimed. For H5230, the note must confirm a sclerosing injection rather than banding or excision. So use the checklist below before submitting.

Every H5230 operative note must include:

• Named sclerosing agent: for example, “5% phenol in almond oil”, not just “sclerosant”
• Volume injected: millilitres per site, or the total volume for the session
• Haemorrhoid grade: recorded on the Goligher scale (Grade I, II or III)
• Number of injection sites: an exact count, such as “three injection sites” rather than “multiple”
• Location: confirmed as above the dentate line (internal haemorrhoids)
• Proctoscope use: the instrument named and its guidance confirmed
• Indication for sclerotherapy: why it was chosen over banding, such as an anticoagulated patient or a Grade I presentation
• Consultant name and GMC number
• Procedure date and location: the hospital or practice name and address

In short, a structured operative note template that prompts for each of these fields at the point of care catches gaps before the claim goes out.

Pre-authorisation: what UK private insurers require for H5230

Many insurers require pre-auth for surgical-schedule procedures, so check each insurer’s current rules before every H5230 encounter. Rules vary by insurer and policy tier. Where pre-auth applies, insurers are likely to decline a claim without a valid reference, and the bill may then fall to the patient or the practice.

However, the table below shows general patterns only, because each policy’s rules differ.

H5230 vs haemorrhoid banding codes: choosing the correct code

Sclerotherapy and rubber band ligation (RBL) are clinically distinct procedures with different CCSD codes, so the operative note decides which one applies. Next, use the decision logic below.

1. Was a chemical sclerosant injected into the haemorrhoid? If yes: H5230.
2. Was a rubber band applied to the haemorrhoid? If yes: the banding code (H5240), not H5230.
3. Were both techniques performed in the same session? CCSD lists H5240 as an unacceptable combination with H5230. Document each technique separately in the operative note, then check the insurer’s rules before claiming.

In short, the clinical difference is simple to state. Sclerotherapy uses a needle and a chemical, while banding uses an applicator and a rubber ring. If the operative note does not say which technique the clinician used, the coder cannot select the correct code. So send unclear notes back to the clinician before you submit the claim, rather than guessing the technique from the procedure name. Finally, the chart below sets the haemorrhoid codes side by side.

Why H5230 claims are denied: causes, prevention, and appeals

First, the table below maps common H5230 denial causes to a prevention step and an appeal route.

Billing multiple haemorrhoid injections in one session

Bill H5230 once per session, however many haemorrhoid sites you inject. The CCSD descriptor is plural (“haemorrhoids”), which supports one charge per session, but confirm the billing unit with the insurer. Treating three haemorrhoids in one sitting still generates a single H5230 charge. However, claim repeat sessions separately by date of service.

The operative note must still record the number of sites injected. Insurers use this detail to assess medical necessity and to tell a single-site procedure from a multi-site session. For example, recording “three injection sites” rather than “multiple sites” protects the claim if the insurer queries the procedure scope.

However, where a clinician treats four or more distinct haemorrhoids in one session, some insurers may ask you to explain why. Record the reason in the operative note to pre-empt this. For example: “Grade II haemorrhoids at three positions; Grade III at the fourth position with early prolapse”. CCSD codes carry no modifiers, so check with the insurer whether it expects extra records for multi-site sessions.

How Pabau handles H5230 claims from booking to payment

Many H5230 denials start before the procedure, when nobody captures the pre-auth code or the insurer’s rate. In Pabau’s claims management software, you store each insurer authorisation as a case and attach it at booking. The code then carries through to the claim without anyone retyping it.

Key capabilities relevant to H5230 billing:

• Insurer price lists: add each insurer with its agreed rate, so Pabau raises the H5230 invoice at the right amount without a manual lookup
• Authorisation cases: store each pre-authorisation as a case, and see claims without one flagged before they go out
• Healthcode submission: send claims to Bupa, AXA Health, Vitality and other insurers without leaving Pabau
• Claim tracking: follow each claim from Pending to Paid, and see the reason when one comes back rejected

The operative note sits in the same patient record as the invoice. As a result, when an insurer queries the agent, grade or site count, the answer is already on file rather than in a separate system.

Fewer H5230 denials, less pre-auth chasing

Pabau stores each insurer’s agreed rate and pre-authorisation code, then submits and tracks the H5230 claim through Healthcode. Rejected claims come back with the reason, so you can fix and resubmit them.

Book a demo

Conclusion

H5230 is one of the simpler codes in the Rectum/Anus section to assign. However, the work is in what surrounds it. The note states the technique, the claim avoids unacceptable combinations, and a pre-authorisation code is in place wherever the insurer wants one.

Start with the operative note template. Then, once it forces the agent, grade, site count and proctoscope fields, most of the denial causes above stop reaching the insurer. If a note is unclear about banding versus injection, send it back to the consultant instead of coding from memory.

To see how authorisation cases and insurer rates carry through to each claim, book a demo of Pabau’s claims workflow.

Continue your research

Billing an excision instead? CCSD code H5100 covers haemorrhoidectomy, the code CCSD lists as an unacceptable combination with H5230.

Coding another Rectum/Anus procedure? CCSD code H0480 explains abdominal revision of restorative proctocolectomy and how it is graded.

Billing other CCSD colorectal codes? Bupa’s CCSD code schedule guide covers the full range of Bupa-accepted procedure codes for colorectal and surgical specialties.

Need the complete Bupa fee schedule? Bupa’s procedure fee schedule on Pabau sets out how Bupa remunerates CCSD-coded procedures by category.

Frequently asked questions